Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11378063 | 0.97 | MEN1 (0.42) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| Hydrochloric Acid SCHEMBL11376627 | 0.82 | ADRB2 (0.40) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL9705215 | 0.77 | MEN1 (0.48) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL21770689 | 0.76 | — | — | |
| SCHEMBL8767641 | 0.74 | PIK3CD (0.48) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL12918859 | 0.74 | MEN1 (0.46) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL24315326 | 0.72 | MEN1 (0.43) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL21127230 | 0.72 | MEN1 (0.43) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL20257921 | 0.72 | MEN1 (0.43) | MEN1KMT2ACHRNB2CHRNA4LTA4H | |
| SCHEMBL16668176 | 0.72 | MEN1 (0.43) | MEN1KMT2ACHRNB2CHRNA4LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827616-B2 | Heterocyclic compounds as pesticides | DISCOVERY PURCHASER CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| US-20200062729-A1 | NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES | DISCOVERY PURCHASER CORPORATION | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827616-B2 | Heterocyclic compounds as pesticides | DDT, CHRM1, ACHE | MEN1 724/4885KMT2A 1690/4885CHRNB2 965/4885 |
| US-20200062729-A1 | NOVEL HETEROCYCLIC COMPOUNDS AS PESTICIDES | CHRM1, DDT, ACHE | MEN1 951/4885KMT2A 1757/4885CHRNB2 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.